Herb Profile

Licorice

Glycyrrhiza glabra

Licorice (Glycyrrhiza glabra) carries a Grade C rating — limited evidence.

Last reviewed: 3 sources citedReport a correctionProfile-wide ·C Limited

Use extra caution Clinically important risk: hypertension, hypokalemia, edema, arrhythmia, and pseudoaldosteronism, especially with chronic/high dose glycyrrhizin exposure. Details

Evidence
Limited Evidence
Typical onset
Varies by prep
Safety rating
Moderate caution
Best for
Anti Inflammatory, Inflammatory signaling
Avoid / review if
Hypertension, Kidney Disease, Heart Failure
Licorice monograph visual
The Hippie Scientist

At a glance

From this profile's structured data
Evidence
Grade C
Safety
Clinically important risk: hypertension, hypokalemia, edema, arrhythmia, and pseudoaldosteronism, especially with chronic/high-dose glycyrrhizin exposure.
Profile context
anti-inflammatory
Next steps

Continue reading

  • If you want to browse more herbsAll herbs

Safety

Safety & Cautions

Clinically important risk: hypertension, hypokalemia, edema, arrhythmia, and pseudoaldosteronism, especially with chronic/high dose glycyrrhizin exposure.

Elevated caution

Caution level: Elevated. One caution category applies — read it before use.

  • Stimulant-Like ProfileStimulant-like or activating caution language is present.
Detailed safety fields

Pregnancy, breastfeeding, and contraindications

  • Hypertension
  • Kidney Disease
  • Heart Failure
  • Hypokalemia
  • Pregnancy
  • And Use Of Digoxin Or Potassium Wasting Diuretics Unless Medically Supervised.
  • High Risk With Diuretics
  • Digoxin
  • Corticosteroids
  • Antihypertensives

Safety classifications

  • Stimulant-Like Profile: Stimulant-like or activating caution language is present.

Full safety note

  • Clinically important risk: hypertension, hypokalemia, edema, arrhythmia, and pseudoaldosteronism, especially with chronic/high dose glycyrrhizin exposure.

Safety labels

  • Stimulant-Like Profile

Evidence-based safety

Caution when combined

Severity and certainty are shown separately. A high-priority caution can still be theoretical: these pairings are screened from shared contraindication mechanisms and are not automatically documented clinical interactions. Provenance identifies the source fields that produced each flag; it does not upgrade the certainty of the pairwise claim.

Evidence

Evidence Summary

Evidence lens

Read as directional context, not settled clinical proof.

LimitedLimited Evidence

Human clinical evidence: Present in source signals

Mechanistic / preclinical: Mechanism mappedInflammatory Signaling Modulation · NF KB Modulation

Research maturity: Emerging researchLong Term Human Evidence May Be Limited.

Safety boundary: Safety note availableClinically important risk: hypertension, hypokalemia, edema, arrhythmia, and pseudoaldosteronism, especially with chronic/high dose glycyrrhizin exposure.

This profile cites 3 human studies.

Study design details
Evidence Grade

Grade C: Limited Evidence

Evaluation of methodological rigor, population reach, and evidence alignment.

Design Match
Meta-analysis
Risk of Bias
Low
Consistency
Not assessed
Strongest recorded design is a meta-analysis, drawn from 4 recorded studies, 1 in people.
How evidence grades work

Each grade reflects the strength and consistency of published human evidence — not marketing claims. Grades are based on study count, design quality, effect size, consistency, and recency.

Strong
Multiple RCTs, consistent direction, adequate effect size
Moderate
Some RCTs or consistent observational data in humans
Preliminary / Mixed
Animal or in-vitro only, or conflicting human data
Traditional / Theoretical
Traditional use only; no controlled human trials
Clinical Study Summaries (5)1 human evidence source · 0 human trials · Participant totals not consistently reported · Consistency not yet classifiable

Filter by study class

Showing 5 of 5 studies.

What the evidence actually shows

This table contains 5 structured sources, including 1 human evidence source; 0 are human trials.

StudyDesignNDoseDurationPopulationOutcomeResult & magnitudeSource

A meta-analysis of 26 clinical trials (985 participants) found small reductions in body weight/BMI but also an increase in diastolic blood pressure. This is a useful benefit-risk tradeoff and reinforces blood-pressure caution.

Background
Meta-analysis

Statistically combines results from multiple eligible studies; confidence still depends on the quality, consistency, and directness of those studies.

A meta-analysis of 26 clinical trials (985 participants) found small reductions in body weight/BMI but also an increase in diastolic blood pressure. This is a useful benefit-risk tradeoff and reinforces blood-pressure caution.PubMed

Herb-Drug Interactions and Their Impact on Pharmacokinetics: An Update

Cheng W et al. · Curr Drug Metab · 2023

Background
Narrative review

Summarizes selected literature without the full prespecified search and selection methods of a systematic review.

PubMed

Toxicological Effects of Glycyrrhiza glabra (Licorice): A Review

Nazari S et al. · Phytother Res · 2017

Background
Narrative review

Summarizes selected literature without the full prespecified search and selection methods of a systematic review.

PubMed

Review of pharmacological effects of Glycyrrhiza sp. and its bioactive compounds

Asl MN et al. · Phytother Res · 2008

Background
Narrative review

Summarizes selected literature without the full prespecified search and selection methods of a systematic review.

PubMed

PMID 42147407

Background
Other / unclear

The study design is not yet classified clearly enough to infer its place in the evidence hierarchy.

A 2026 literature analysis of 120 reports/trials identified recurrent licorice-related adverse-reaction patterns including hypokalemia/pseudohyperaldosteronism, hypertension/arrhythmia and allergy. Higher-risk contexts included older age, hepatic/renal disease, off-label dosing and co-use with thiazide diuretics or drugs that disturb electrolytes/heart rhythm.PubMed

Dosing & Timing

No standardized dose
Preparation specific; use standardized product label for Differentiate glycyrrhizin containing licorice from deglycyrrhizinated licorice (DGL) and require source backed dosage review before therapeutic claims.
How Licorice works

Simplified mechanism pathway based on preclinical and pharmacological evidence. Does not confirm clinical efficacy.

Mechanism Pathway — How Licorice Works

How Licorice WorksLicorice acts on biological target pathways via anti inflammatory, leading to anti inflammatory.LicoriceBiological TargetBiological pathwayAnti InflammatoryAnti InflammatoryObservable outcomeNF KB InhibitionParallel pathway
CompoundTarget / ReceptorMechanismEffect / Outcome
Mechanisms & biological pathways (preclinical)
  • Inflammatory Signaling Modulation
  • NF KB Modulation

Active Compounds

Key constituents studied in Licorice, with full pharmacology and safety profiles.

Compare related active botanicals

Explore botanicals with similar chemistry, effects, or safety considerations in the Botanical Activity Atlas.

Guides that use Licorice

Compare & Sourcing

Compare side-by-side tradeoffs or verify active marker guidelines.

Sourcing options

Licorice Root product picks

Recommendation status

Product recommendations are not shown for this profile because the current site safety and monetization policy does not permit them.

Product form & quality guidelines

When sourcing Licorice, verify the label for:

  • Standardized extract: Confirm active content percentages on the supplement facts panel (e.g. standardized to specific marker compounds) rather than simple raw herb weights.
  • Third-party testing: Look for independent purity labels (USP, NSF, ConsumerLab, or Eurofins) to ensure the product is free from heavy metals, solvents, and contaminants.
  • Form bioavailability: Ensure the form matches evidence-supported configurations (e.g. standardized active extracts like bacosides, withanolides, or curcuminoids) for optimal onset and digestion tolerance.

Safety first · Harm reduction

This information is educational and not medical advice. Start low, avoid risky combinations, and consult a licensed clinician before making health decisions—especially if you use medications, have diagnosed conditions, or are pregnant/breastfeeding.

Learn how we evaluate confidence, safety, and intensity on the methodology page.

Editorial Review

Checked against primary sources, cited evidence, and contraindication language before publication. Evidence claims, safety language, and affiliate modules are reviewed independently. Not personal medical advice.

Editorial Standards →

Help improve this profile

Was this useful for your research?

These controls record only the page and the structured choice you make when analytics consent is enabled. Please don’t include personal medical information in research requests.

Was this evidence summary clear?

Did you find what you were researching?

Free safety checklist

Get the Licorice research notes

Evidence summaries, dosing context, and safety updates for this herb — straight to your inbox.

We use your email to send the checklist and occasional evidence-first supplement updates. Unsubscribe anytime. Privacy policy.